Patil Harsha V, Patil Virendra C, Patange Aparna P, Asim Khan Mohammad
Department of Microbiology, Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, IND.
Department of Medicine, Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, IND.
Cureus. 2024 Aug 3;16(8):e66089. doi: 10.7759/cureus.66089. eCollection 2024 Aug.
Background Diabetic foot ulcers (DFUs) are prevalent complications of diabetes mellitus, often leading to severe infections and adverse clinical outcomes. , a gram-negative bacterium, has emerged as a significant causative agent in DFU infections, raising concerns due to its increasing antibiotic resistance, particularly in extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL) production. Aim This study aimed to comprehensively assess the prevalence, antibiotic resistance profiles, and clinical correlates of ESBL- and MBL-producing isolates specifically derived from DFUs. Methods A cross-sectional observational study was conducted at Krishna Vishwa Vidyapeeth from January 2023 to June 2023, involving 126 patients diagnosed with DFUs. Clinical and demographic data were collected, and wound swabs underwent microbiological analysis. Phenotypic detection methods were employed to identify ESBL and MBL production, followed by standardized antibiotic susceptibility testing. Results Among the 126 isolates tested, 36 (28.6%) were identified as ESBL-producing and 21 (16.7%) as MBL-producing strains. ESBL-producing isolates exhibited high resistance rates to antibiotics such as ampicillin (92.3%), amoxicillin-acid (84.6%), and cephalosporins, including ceftriaxone (76.9%), and cefepime (73.8%). MBL-producing isolates demonstrated even broader resistance profiles, including resistance to fluoroquinolones (ciprofloxacin, 60.0%; levofloxacin, 57.1%), aminoglycosides (gentamicin, 42.9%), and carbapenems (meropenem, 38.1%; imipenem, 35.7%). Conclusion This study identifies a significant prevalence of ESBL- and MBL-producing in DFUs, showcasing high antibiotic resistance rates. Comorbidities correlate significantly with the presence of resistant isolates, necessitating treatment strategies for effective management.
背景 糖尿病足溃疡(DFUs)是糖尿病常见的并发症,常导致严重感染和不良临床结局。 ,一种革兰氏阴性菌,已成为DFU感染的重要病原体,因其日益增加的抗生素耐药性,尤其是产超广谱β-内酰胺酶(ESBL)和金属β-内酰胺酶(MBL),引起了人们的关注。目的 本研究旨在全面评估特别源自DFUs的产ESBL和MBL菌株的流行率、抗生素耐药谱以及临床相关性。方法 2023年1月至2023年6月在克利须那维斯瓦维迪亚佩特进行了一项横断面观察性研究,纳入126例诊断为DFUs的患者。收集临床和人口统计学数据,并对伤口拭子进行微生物分析。采用表型检测方法鉴定ESBL和MBL的产生,随后进行标准化的抗生素敏感性试验。结果 在检测的126株菌株中,36株(28.6%)被鉴定为产ESBL菌株,21株(16.7%)为产MBL菌株。产ESBL菌株对氨苄西林(92.3%)、阿莫西林-克拉维酸(84.6%)和头孢菌素类抗生素(包括头孢曲松(76.9%)和头孢吡肟(73.8%))表现出高耐药率。产MBL菌株表现出更广泛的耐药谱,包括对氟喹诺酮类(环丙沙星,60.0%;左氧氟沙星,57.1%)、氨基糖苷类(庆大霉素,42.9%)和碳青霉烯类(美罗培南,38.1%;亚胺培南,35.7%)的耐药。结论 本研究发现DFUs中产ESBL和MBL的情况很普遍,显示出高抗生素耐药率。合并症与耐药菌株的存在显著相关,需要有效的治疗策略来进行管理。